Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 17, 2019
- Accepted after revision March 6, 2019
- Published online May 15, 2019.
Article Versions
- Latest version (May 2, 2019 - 07:38).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by American Journal of Neuroradiology
Author Information
- aFrom the American University of Integrative Sciences (H.A.V.), Brampton, Ontario, Canada
- bDepartment of Radiology (F.H.), George Washington University Hospital, Washington, DC
- cProgressive Radiology (R.K.T.), George Washington University, Washington, DC.
- Please address correspondence to Raymond K. Tu, MD, MS, FACR, Progressive Radiology, George Washington University, United Medical Center, 2121 K St NW, Suite 100, Washington, DC 20037; e-mail: Raymond.Tu{at}progressiveradiology.net; @RayTu10
Altmetrics
Cited By...
Jump to section
- Article
- Abstract
- ABBREVIATIONS:
- What are Chimeric Antigen Receptor T-Cells?
- Who Benefits from CAR T-Cell Therapy?
- How Is CAR T-Cell Therapy Delivered to Patients?
- What Are the Major Toxicities of CAR T-Cell Therapy and How Are They Graded?
- What Are the Neuroradiologic Findings in Patients Receiving CAR T-Cell Therapy?
- What are the Neuroradiologic Recommendations in Patients Receiving CAR T-Cell Therapy?
- What Are the Challenges in Implementing CAR T-Cell Therapy?
- REFERENCES
- Info & Metrics
- Responses
- References